Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 10, 2024 4
4 Jan 10, 2024 4
4 Jan 10, 2024 4
4 Jan 10, 2024 4
144 Jan 9, 2024
144 Jan 9, 2024
144 Jan 9, 2024
144 Jan 9, 2024
4 Jan 3, 2024 4
144 Jan 2, 2024
4 Dec 28, 2023 OWNERSHIP DOCUMENT
SC 13D/A Dec 28, 2023 SC 13D/A
4 Dec 19, 2023 FORM 4 SUBMISSION
144 Dec 18, 2023
EFFECT Nov 27, 2023
CORRESP Nov 21, 2023
UPLOAD Nov 15, 2023
4 Nov 13, 2023 FORM 4 SUBMISSION
144 Nov 9, 2023
8-K Nov 8, 2023 8-K
S-3 Nov 8, 2023 S-3
10-Q Nov 8, 2023 10-Q
8-K Nov 8, 2023 8-K
SC 13G/A Oct 10, 2023
8-K Sep 1, 2023 8-K
← Newer Page 8 of 35 · 855 filings Older →